These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 19180663

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale.
    Ben-Assa E, Rengifo-Moreno P, Al-Bawardy R, Kolte D, Cigarroa R, Cruz-Gonzalez I, Sakhuja R, Elmariah S, Pomerantsev E, Vaina LM, Ning M, Buonanno FS, Hung JW, Inglessis I, Palacios IF.
    JACC Cardiovasc Interv; 2020 Feb 10; 13(3):293-302. PubMed ID: 32029246
    [Abstract] [Full Text] [Related]

  • 25. Percutaneous patent foramen ovale closure using Helex and Amplatzer devices without intraprocedural echocardiographic guidance.
    Siddiqui IF, Michaels AD.
    J Interv Cardiol; 2011 Jun 10; 24(3):271-7. PubMed ID: 21114532
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism.
    Spies C, Khandelwal A, Timmemanns I, Kavinsky CJ, Schräder R, Hijazi ZM.
    Catheter Cardiovasc Interv; 2008 Dec 01; 72(7):966-70. PubMed ID: 18942060
    [Abstract] [Full Text] [Related]

  • 29. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
    Białkowski J, Wawrzyńczyk M, Karwot B, Fiszer R, Knop M, Szkutnik M.
    Kardiol Pol; 2012 Dec 01; 70(11):1142-6. PubMed ID: 23180522
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Percutaneous transcatheter closure of high-risk patent foramen ovale in the elderly.
    Takafuji H, Hosokawa S, Ogura R, Hiasa Y.
    Heart Vessels; 2019 Oct 01; 34(10):1657-1662. PubMed ID: 30868214
    [Abstract] [Full Text] [Related]

  • 35. Effect of percutaneous atrial septal defect and patent foramen ovale device closure on degree of aortic regurgitation.
    Loar RW, Johnson JN, Cabalka AK, Cetta F, Hagler DJ, Eidem BW, Taggart NW.
    Catheter Cardiovasc Interv; 2013 Jun 01; 81(7):1234-7. PubMed ID: 23239614
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
    Steinberg DH, Bertog SC, Momberger J, Franke J, Hofmann I, Renkhoff K, Joy S, Vaskelyte L, Sievert H.
    Catheter Cardiovasc Interv; 2015 Jun 01; 85(7):1262-7. PubMed ID: 24948394
    [Abstract] [Full Text] [Related]

  • 39. Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder?
    Fateh-Moghadam S, Steeg M, Dietz R, Bocksch W.
    Catheter Cardiovasc Interv; 2009 Feb 15; 73(3):361-6. PubMed ID: 19133676
    [Abstract] [Full Text] [Related]

  • 40. Patent foramen ovale closure for migraine prevention: the subject is still open.
    Dodick DW.
    JACC Cardiovasc Interv; 2010 Mar 15; 3(3):288-9. PubMed ID: 20298986
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.